Literature DB >> 12761117

A mosaic pathogenicity island made up of the locus of enterocyte effacement and a pathogenicity island of Escherichia coli O157:H7 is frequently present in attaching and effacing E. coli.

Stefano Morabito1, Rosangela Tozzoli, Eric Oswald, Alfredo Caprioli.   

Abstract

Enteropathogenic Escherichia coli (EPEC) and enterohemorragic E. coli (EHEC) possess a pathogenicity island (PAI), termed the locus of enterocyte effacement (LEE), which confers the capability to cause the characteristic attaching and effacing lesions of the brush border. Due to this common property, these organisms are also termed attaching and effacing E. coli (AEEC). Sequencing of the EHEC O157 genome recently revealed the presence of other putative PAIs in the chromosome of this organism. In this article, we report on the presence of four of those PAIs in a panel of 133 E. coli strains belonging to different pathogroups and serotypes. One of these PAIs, termed O122 in strain EDL 933 and SpLE3 in strain Sakai, was observed in most of the AEEC strains examined but not in the other groups of E. coli. It was also found to contain the virulence-associated gene efa1/lifA. In EHEC O157, PAI O122 is located 0.7 Mb away from the LEE. Conversely, we demonstrated that in many EHEC non-O157 strains and EPEC strains belonging to eight serogroups, PAI O122 and the LEE are physically linked to form a cointegrated structure. This structure can be considered a mosaic PAI that could have been acquired originally by AEEC. In some clones, such as EHEC O157, the LEE-O122 mosaic PAI might have undergone recombinational events, resulting in the insertion of the portion referred to as PAI O122 in a different location.

Entities:  

Mesh:

Year:  2003        PMID: 12761117      PMCID: PMC155766          DOI: 10.1128/IAI.71.6.3343-3348.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  43 in total

Review 1.  Horizontal gene transfer and the origin of species: lessons from bacteria.

Authors:  F de la Cruz; J Davies
Journal:  Trends Microbiol       Date:  2000-03       Impact factor: 17.079

2.  Isolation and characterization of mini-Tn5Km2 insertion mutants of enterohemorrhagic Escherichia coli O157:H7 deficient in adherence to Caco-2 cells.

Authors:  I Tatsuno; H Kimura; A Okutani; K Kanamaru; H Abe; S Nagai; K Makino; H Shinagawa; M Yoshida; K Sato; J Nakamoto; T Tobe; C Sasakawa
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

3.  Genome sequence of enterohaemorrhagic Escherichia coli O157:H7.

Authors:  N T Perna; G Plunkett; V Burland; B Mau; J D Glasner; D J Rose; G F Mayhew; P S Evans; J Gregor; H A Kirkpatrick; G Pósfai; J Hackett; S Klink; A Boutin; Y Shao; L Miller; E J Grotbeck; N W Davis; A Lim; E T Dimalanta; K D Potamousis; J Apodaca; T S Anantharaman; J Lin; G Yen; D C Schwartz; R A Welch; F R Blattner
Journal:  Nature       Date:  2001-01-25       Impact factor: 49.962

4.  A novel locus of enterocyte effacement (LEE) pathogenicity island inserted at pheV in bovine Shiga toxin-producing Escherichia coli strain O103:H2.

Authors:  J Jores; L Rumer; S Kiessling; J B Kaper; L H Wieler
Journal:  FEMS Microbiol Lett       Date:  2001-10-16       Impact factor: 2.742

5.  Complete genome sequence of enterohemorrhagic Escherichia coli O157:H7 and genomic comparison with a laboratory strain K-12.

Authors:  T Hayashi; K Makino; M Ohnishi; K Kurokawa; K Ishii; K Yokoyama; C G Han; E Ohtsubo; K Nakayama; T Murata; M Tanaka; T Tobe; T Iida; H Takami; T Honda; C Sasakawa; N Ogasawara; T Yasunaga; S Kuhara; T Shiba; M Hattori; H Shinagawa
Journal:  DNA Res       Date:  2001-02-28       Impact factor: 4.458

6.  Parallel evolution of virulence in pathogenic Escherichia coli.

Authors:  S D Reid; C J Herbelin; A C Bumbaugh; R K Selander; T S Whittam
Journal:  Nature       Date:  2000-07-06       Impact factor: 49.962

7.  The virulence plasmid pWR100 and the repertoire of proteins secreted by the type III secretion apparatus of Shigella flexneri.

Authors:  C Buchrieser; P Glaser; C Rusniok; H Nedjari; H D'Hauteville; F Kunst; P Sansonetti; C Parsot
Journal:  Mol Microbiol       Date:  2000-11       Impact factor: 3.501

8.  A large toxin from pathogenic Escherichia coli strains that inhibits lymphocyte activation.

Authors:  J M Klapproth; I C Scaletsky; B P McNamara; L C Lai; C Malstrom; S P James; M S Donnenberg
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

9.  Typing of intimin genes in human and animal enterohemorrhagic and enteropathogenic Escherichia coli: characterization of a new intimin variant.

Authors:  E Oswald; H Schmidt; S Morabito; H Karch; O Marchès; A Caprioli
Journal:  Infect Immun       Date:  2000-01       Impact factor: 3.441

Review 10.  Infectious disease as an evolutionary paradigm.

Authors:  J Lederberg
Journal:  Emerg Infect Dis       Date:  1997 Oct-Dec       Impact factor: 6.883

View more
  32 in total

1.  Evidence for a hybrid genomic island in verocytotoxin-producing Escherichia coli CL3 (serotype O113:H21) containing segments of EDL933 (serotype O157:H7) O islands 122 and 48.

Authors:  Songhai Shen; Mariola Mascarenhas; Kris Rahn; James B Kaper; Mohamed A Karmali; Mohamed A Karmal
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

2.  Detection of toxB, a plasmid virulence gene of Escherichia coli O157, in enterohemorrhagic and enteropathogenic E. coli.

Authors:  Rosangela Tozzoli; Alfredo Caprioli; Stefano Morabito
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

3.  Active genetic elements present in the locus of enterocyte effacement in Escherichia coli O26 and their role in mobility.

Authors:  Maite Muniesa; Mark A Schembri; Nadja Hauf; Trinad Chakraborty
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

4.  Genetic analysis of enteropathogenic and enterohemorrhagic Escherichia coli serogroup O103 strains by molecular typing of virulence and housekeeping genes and pulsed-field gel electrophoresis.

Authors:  Lothar Beutin; Stefan Kaulfuss; Sylvia Herold; Eric Oswald; Herbert Schmidt
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

5.  Genomic O island 122, locus for enterocyte effacement, and the evolution of virulent verocytotoxin-producing Escherichia coli.

Authors:  Paulina Konczy; Kim Ziebell; Mariola Mascarenhas; Aileen Choi; Corinne Michaud; Andrew M Kropinski; Thomas S Whittam; Mark Wickham; Brett Finlay; Mohamed A Karmali
Journal:  J Bacteriol       Date:  2008-06-27       Impact factor: 3.490

6.  Evidence of pathogenic subgroups among atypical enteropathogenic Escherichia coli strains.

Authors:  Isabel C A Scaletsky; Katia R S Aranda; Tamara B Souza; Neusa P Silva; Mauro B Morais
Journal:  J Clin Microbiol       Date:  2009-09-16       Impact factor: 5.948

7.  Prevalence and characteristics of the O122 pathogenicity island in typical and atypical enteropathogenic Escherichia coli strains.

Authors:  Mônica A M Vieira; Fábia A Salvador; Rosa M Silva; Kinue Irino; Tânia M I Vaz; Anna C Rockstroh; Beatriz E C Guth; Tânia A T Gomes
Journal:  J Clin Microbiol       Date:  2010-02-24       Impact factor: 5.948

8.  Distribution, functional expression, and genetic organization of Cif, a phage-encoded type III-secreted effector from enteropathogenic and enterohemorrhagic Escherichia coli.

Authors:  Estelle Loukiadis; Rika Nobe; Sylvia Herold; Clara Tramuta; Yoshitoshi Ogura; Tadasuke Ooka; Stefano Morabito; Monique Kérourédan; Hubert Brugère; Herbert Schmidt; Tetsuya Hayashi; Eric Oswald
Journal:  J Bacteriol       Date:  2007-09-14       Impact factor: 3.490

9.  Production of verotoxin and distribution of O islands 122 and 43/48 among verotoxin-producing Escherichia coli O103:H2 isolates from cattle and humans.

Authors:  Musafiri Karama; Roger P Johnson; Robert Holtslander; Carlton L Gyles
Journal:  Appl Environ Microbiol       Date:  2008-11-07       Impact factor: 4.792

10.  Derivation of Escherichia coli O157:H7 from its O55:H7 precursor.

Authors:  Zhemin Zhou; Xiaomin Li; Bin Liu; Lothar Beutin; Jianguo Xu; Yan Ren; Lu Feng; Ruiting Lan; Peter R Reeves; Lei Wang
Journal:  PLoS One       Date:  2010-01-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.